The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
A genetic study in a cohort of over 9,000 colorectal cancer patients and a control group of over 18,000 found a 23% reduction in the incidence of colorectal cancer based on genotypes that increase oleic and palmitoleic acids (both predominantly rich in plant oils), and arachidonic acid, respectively.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The predominantly inflammatory nature of arachidonic acid is a probable underlying cause. (10)
A genetic study in a cohort of over 9,000 colorectal cancer patients and a control group of over 18,000 found a 5% reduction and 5% increase in the incidence of colorectal cancer based on genotypes that increase linoleic acid, and arachidonic acid, respectively.